Medicine
Optison Perflutren Protein-Type A Microspheres 30 mg/0.66 mg per 3 mL injection
Optison Perflutren Protein-Type A Microspheres 30 mg/0.66 mg per 3 mL injection is a prescription medicine containing Human albumin microspheres and Perflutren for intravenous use, marketed by GE Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. at room temperature (up to 25°C or 77°F) for up to 24 hours is…
Key facts
- Active ingredient (INN)
- Human albumin microspheres and Perflutren
- Brand
- Optison Perflutren Protein-Type A Microspheres
- Strength
- 30 mg/0.66 mg per 3 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 5 vials of 3 mL, 18 vials of 3 mL
- Marketing authorisation holder
- GE Healthcare
- Manufacturer
- GE Healthcare
- Origin register
- US FDA, United States
- Storage
- Do not freeze. at room temperature (up to 25°C or 77°F) for up to 24 hours is permitted.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 January 2002
- Identifiers
- DailyMed set ID 46bcf276-d423-408a-a410-f11383406a94NDC 0407-2707Application NDA020899
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial, single-use in 1 carton / 3 mL in 1 vial, single-use | 0407-2707-03 | GE Healthcare | 2 January 2002 |
| 18 vial, single-use in 1 carton / 3 mL in 1 vial, single-use | 0407-2707-18 | GE Healthcare | 2 January 2002 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Human albumin microspheres and Perflutren is a fixed-dose combination medicine. It is available as injection for intravenous use. MedsAcross supplies Human albumin microspheres and Perflutren for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Human albumin microspheres and PerflutrenFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Optison Perflutren Protein-Type A Microspheres prescribing information (GE Healthcare) · U.S. National Library of Medicine, DailyMed
Need Optison Perflutren Protein-Type A Microspheres 30 mg/0.66 mg per 3 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.